Groundwork BioAg Revenue and Competitors

Moshav Mazor,

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Groundwork BioAg's estimated annual revenue is currently $8.4M per year.(i)
  • Groundwork BioAg's estimated revenue per employee is $155,000

Employee Data

  • Groundwork BioAg has 54 Employees.(i)
  • Groundwork BioAg grew their employee count by 8% last year.

Groundwork BioAg's People

NameTitleEmail/Phone
1
CTO / VP Research & DevelopmentReveal Email/Phone
2
CEOReveal Email/Phone
3
Co-Founder, Chief Growth Officer, DYNOMYCO General ManagerReveal Email/Phone
4
Chief Financial OfficerReveal Email/Phone
5
Marketing ManagerReveal Email/Phone
6
General ManagerReveal Email/Phone
7
Carbon Business leadReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$81.4M37540%N/AN/A
#2
$16.9M10922%N/AN/A
#3
$156.1M120-70%$145MN/A
#4
$2.9M37-24%$150MN/A
#5
$1.3M170%$459.5MN/A
#6
$49.2M25415%$180.7MN/A
#7
$7M45-2%N/AN/A
#8
$256.3M8409%$168.5MN/A
#9
$4.2M27-7%N/AN/A
#10
$10.1M655%N/AN/A
Add Company

What Is Groundwork BioAg?

Groundwork BioAg produces highly-effective mycorrhizal inoculants for commercial agriculture. Containing concentrated and vigorous beneficial fungi, Rootellaâ„¢ inoculants significantly improve soil nutrient uptake in plants. Rootellaâ„¢ increases crop yields, improves resistance to several types of stress, and reduces fertilizer requirements. Groundwork BioAg has demonstrated significant yield increases in numerous major crops, including corn, soybean, sorghum, tomato, and onion.

keywords:N/A

N/A

Total Funding

54

Number of Employees

$8.4M

Revenue (est)

8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Groundwork BioAg News

2022-04-17 - Groundwork BioAg mycorrhizal inoculant available in top ag ...

Groundwork BioAg has established commercial operations across most of the world's major agricultural markets, including the United States,...

2022-04-17 - GROUNDWORK BIOAG'S GLOBAL COMMERCIAL BUSINESS EXPANDS TO CHINA - Benzinga

Yossi Kofman, co-founder and CEO of Groundwork BioAg. "As the 'Queen of Biologicals,' highly concentrated mycorrhizal inoculants enable all...

2022-04-17 - Groundwork BioAg's Global Commercial Business Expands to ...

As part of its steady global expansion, Groundwork BioAg opened a representative office in China to serve one of the world's leading...